insights_auto
Why is 2U3 up 2.96%?
Dive Deeperchevron_right
2U3:FRA
Alcon AG
€ 62.52
arrow_upward
+2.96%(+1.80) 1D
10-р сарын 23, 09:07:59 (GMT+2) · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2U3...
Open
€ 62.52
High
€ 62.52
Low
€ 62.52
Mkt. cap
28.76 тэрбум
Avg. vol.
227.00
Volume
0.00
52-wk high
€ 73.96
52-wk low
€ 51.78
No. of employees
25 мян
Open
€ 62.52
High
€ 62.52
Low
€ 62.52
Mkt. cap
28.76 тэрбум
Avg. vol.
227.00
Volume
0.00
52-wk high
€ 73.96
52-wk low
€ 51.78
No. of employees
25 мян
News stories
From web sources and news partners
GuruFocus
·
13 цагийн өмнө
Alcon Inc (ALC) Shares Surge 4.8% -- What GF Score of 74 Tells I
Pharmaceutical Executive
·
22 цагийн өмнө
Roundup: Alcon Acquires Neurotech and Encelto, Ai Proteins Enters Research Collaboration and License Agreement with Astellas Pharma
Yahoo Finance
·
1 өдрийн өмнө
Alcon's Neurotech Acquisition Offers Significant Growth Potential, Needham Says
Yahoo Finance
·
2 өдрийн өмнө
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25 мян
Founded1945
HeadquartersЖенев, Geneva, Швейцари
Sector-
Websitealcon.com